doi: 10.1208/s12249-022-02385-8.
- PMID: 35962264
- DOI: 10.1208/s12249-022-02385-8
Abstract
Delta-9-tetrahydrocannabinol (THC) is one of the most effective antinociceptive agents used in the treatment of peripheral neuropathy. THC is highly lipophilic and susceptible to thermal and oxidative degradation. Identifying appropriate solvents in which THC is stable as well as adequately solubilized is crucial in developing topical dosage forms. Lipid solvent systems are of utmost utility and relevance for formulating highly lipophilic drugs. Hence, the objective of this project was to screen the solubility of THC in lipidic excipients, monitor THC content in the selected vehicles during stability, and study the influence of these excipients on permeation of THC across skin. The solubility of THC in liquid lipid excipients was in the range of 421 to 500 mg/g. The solubility of THC in solid lipid excipients was in the range of 250 to 750 mg/g. THC in its neat form was poorly stable, but when dissolved in lipid-based excipients, its stability improved significantly. THC in lipid excipients was more stable at 4 ± 3°C compared to samples stored at 25 ± 2°C. The antioxidants (butylated hydroxytoluene and ascorbyl palmitate) used in the excipients further improved the stability of THC. The results demonstrated that the liquid and solid lipid excipients used in the study could solubilize THC freely and mitigate the degradation of THC significantly. The binary combination of lipid excipients enhanced THC skin permeation and retention, demonstrating the potential for topical formulation development of THC.
Keywords: delta-9-tetrahydrocannabinol, lipid excipients, permeation enhancers, skin permeability, solubility
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.AAPS PharmSciTech. 2011 Jun;12(2):723-31. doi: 10.1208/s12249-011-9639-5. Epub 2011 Jun 3.PMID: 21637944 Free PMC article.
-
The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.Eur J Pharm Sci. 2017 Nov 15;109:21-30. doi: 10.1016/j.ejps.2017.07.003. Epub 2017 Jul 20.PMID: 28736128
-
Different pharmaceutical preparations of Δ9 -tetrahydrocannabinol differentially affect its behavioral effects in rats.Addict Biol. 2020 May;25(3):e12745. doi: 10.1111/adb.12745. Epub 2019 Apr 2.PMID: 30938471
-
Natural surfactant-based topical vehicles for two model drugs: Influence of different lipophilic excipients on in vitro/in vivo skin performance.Int J Pharm. 2009 Nov 3;381(2):220-30. doi: 10.1016/j.ijpharm.2009.07.007. Epub 2009 Jul 16.PMID: 19616085
-
Determination of delta 9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography.J Chromatogr. 1981 Feb 6;206(1):117-23. doi: 10.1016/s0021-9673(00)82611-4.PMID: 6260828
References
-
- O’Hearn S, Diaz P, Wan B, DeAngelis C, Lao N, Malek L, Chow E, Blake A. Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: A selected review of preclinical studies. Annals of Palliative Medicine. 2017;6(S2):S209–14. – DOI
-
- Watson J, Dyck P. Peripheral neuropathy: A practical approach to diagnosis and symptom management. Mayo Clin Proc. 2015;90(7):940–51. – DOI
-
- G C, KM D, RE C (2022) Peripheral neuropathy: Evaluation and differential diagnosis. [online] PubMed. Available at: < https://pubmed.ncbi.nlm.nih.gov/33320513/ > [Accessed 21 April 2022].
-
- Cruccu G, Truini A. A review of neuropathic pain: From guidelines to clinical practice. Pain Ther. 2017;6(S1):35–42. – DOI
-
- Theunissen E, Kauert G, Toennes S, Moeller M, Sambeth A, Blanchard M, Ramaekers J. Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology. 2011;220(2):341–50. – DOI
MeSH terms
Substances
